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Background: Altered DNA methylation has been associated with various diseases.
Objective: We evaluated the association between levels of methylation in leukocyte DNA at long
interspersed nuclear element 1 (LINE-1) and genetic and non-genetic characteristics of 892 control
participants from the Spanish Bladder Cancer/EPICURO study.
Methods: We determined LINE-1 methylation levels by pyrosequencing. Individual data included
demographics, smoking status, nutrient intake, toenail concentrations of 12 trace elements,
xenobiotic metabolism gene variants, and 515 polymorphisms among 24 genes in the one-carbon
metabolism pathway. To assess the association between LINE-1 methylation levels (percentage of
methylated cytosines) and potential determinants, we estimated beta coefficients (βs) by robust
linear regression.
Results: Women had lower levels of LINE-1 methylation than men (β = –0.7, p = 0.02). Persons
who smoked blond tobacco showed lower methylation than nonsmokers (β = –0.7, p = 0.03). Arsenic
toenail concentration was inversely associated with LINE-1 methylation (β = –3.6, p = 0.003). By
contrast, iron (β = 0.002, p = 0.009) and nickel (β = 0.02, p = 0.004) were positively associated
with LINE-1 methylation. Single nucleotide polymorphisms (SNPs) in DNMT3A (rs7581217per allele, β = 0.3, p = 0.002), TCN2 (rs9606756-GG, β = 1.9, p = 0.008; rs4820887-AA, β = 4.0,
p = 4.8 × 10–7; rs9621049-TT, β = 4.2, p = 4.7 × 10–9), AS3MT (rs7085104-GG, β = 0.7, p = 0.001),
SLC19A1 (rs914238, TC vs. TT: β = 0.5 and CC vs. TT: β = –0.3, global p = 0.0007) and MTHFS
(rs1380642, CT vs. CC: β = 0.3 and TT vs. CC; β = –0.8, global p = 0.05) were associated with
LINE-1 methylation.
Conclusions: We identified several characteristics, environmental factors, and common genetic
variants that predicted DNA methylation among study participants.
Key words: DNA methylation, epigenetics, LINE-1, one-carbon metabolism gene variants,
smoking, trace elements. Environ Health Perspect 121:650–656 (2013). http://dx.doi.org/10.1289/
ehp.1206068 [Online 3 April 2013]

DNA methylation plays a fundamental role
in regulation of gene expression, genomic
imprinting, X-chromosome inactivation, and
repression of transposable elements (Jones
and Liang 2009). Aberrant DNA methylation
has been associated with various cancers and
with developmental, autoimmune, and other
chronic diseases (Robertson 2005). Global
DNA methylation can be directly quantified
by measuring 5-methylcytosine content of
the genome, or it can be estimated based on
methylation of repetitive sequences such as
Alu elements or long interspersed nuclear element 1 (LINE-1) (Yang et al. 2004). Age, sex,
smoking, and arsenic and lead exposures have
been associated with DNA methylation, but
findings have been inconsistent among studies
(Breitling et al. 2011; El-Maarri et al. 2007;
Fraga et al. 2005; Fuke et al. 2004; Terry et al.
2011). The folate and methionine-dependent
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one-carbon metabolism pathway could modulate DNA methylation by altering the level
of S-adenosylmethionine (SAM), the principal source of methyl groups (Ulrey et al.
2005). Genetic variants might also influence the methylation of CpG loci locally, or
might have a global influence on methyla
tion throughout the genome. For example,
a single nucleotide polymorphism (SNP) in
TRPC3 (transient receptor potential cation
channel, subfamily C, member 3)-isoform 2
has been reported to regulate the methylation
status of its own promoter (Martin-Trujillo
et al. 2011), and variants of the methylene
tetrahydrofolate reductase gene (MTHFR)
have been associated with global DNA
hypomethylation (Castro et al. 2004; Friso
et al. 2002). However, although the determinants of global and site-specific methylation
are widely assumed to be likely contributors
volume

to health and disease, they are poorly defined
at this time.
Assessing the impact of both genetic and
non-genetic factors on global DNA methyla
tion may improve our understanding of the
molecular pathogenesis of many common
diseases. Therefore, we investigated associations
of global DNA methylation in LINE-1 from
bisulfite-modified granulocyte DNA with
genetic variants and personal, demographic,
lifestyle, and environmental characteristics.

Methods
Study population. The study population,
design, and data collection have been previously described (García-Closas M et al. 2005).
Briefly, participating individuals were controls
from the Spanish Bladder Cancer/EPICURO
study who were admitted to hospitals in five
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regions of Spain for a range of conditions
including hernia, fractures, and other non
cancer diseases, and were 20–81 years of age.
We collected demographic and exposure information at the hospitals using computer-assisted
personal interviews. Of a total of 1,271 controls
who agreed to participate in the study and were
interviewed, 1,056 provided blood for DNA
extraction. We excluded 23 subjects because
of inadequate or poor quality DNA (n = 15)
or missing smoking status data (n = 8). Three
subjects with missing data on smoking status
were included because they had data on other
variables including age, sex, region, and body
mass index (BMI). To ensure homogeneity, we
also excluded one non-Caucasian individual,
leaving 925 individuals with granulocyte DNA
for bisulfite modification and pyrosequencing.
Pyrosequencing failed in 33 individuals; thus,
the final study population for the present analysis included 892 participants. We obtained
written informed consent from all participants, and the study was approved by the local
Spanish institutional review boards and U.S.
National Cancer Institute.
Quantification of LINE-1 methylation.
We extracted granulocyte DNA using standard methods (García-Closas M et al. 2005).
We carried out bisulfite conversion of DNA
using the EZ-96 DNA Methylation-Gold™ kit
(Zymo Research, Irvine, CA, USA) according
to the manufacturer’s recommendations. We
carried out polymerase chain reaction (PCR)
amplification of bisulfite-modified DNA using
a set of forward and reverse primers reported
previously (Estécio et al. 2007). To quantify
the methylation level of each of the first four
CpG sites next to the pyrosequencing primer,
we performed sequencing of the PCR product
by pyrosequencing, using the PyroMark™ Q24
System (QIAGEN, Valencia, CA, USA) as recommended by the manufacturer. The first four
were the CpGs from which we could obtain
methylation values of all samples. We extracted
the methylation level at each CpG site using
the PyroMark™ application software, version
2.0.6 (QIAGEN), and we expressed the value
as the percentage of methylated cytosines over
the sum of methylated and unmethylated cytosines. We used the average methylation level
of the first four LINE-1 CpG sites as a surrogate marker of the global DNA methyla
tion level. To determine whether changes in
blood cell populations affect LINE-1 methyla
tion levels, we analyzed LINE-1 methylation
in independently purified granulocyte and
lymphocyte samples. The results showed no
significant difference in LINE-1 methylation
between granulocyte and lymphocyte samples,
thus suggesting that variation in the distribution of peripheral blood cell populations
among participants would not contribute to
variation in global DNA methylation (data
not shown). For the present study, we used
Environmental Health Perspectives •
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DNA extracted from granulocytes to quantify
DNA methylation. As a quality control measure, we measured LINE-1 methylation in 129
randomly selected duplicate samples and the
within-sample coefficient of variation (CV)
was 4.0%. In the analysis, we used the average
of the duplicates for those samples.
Nutritional assessment. We estimated
the usual intake of vitamins B1, B2, B3, B6,
and B12, folate, protein, alcohol, fruit, and
vegetables over the 5 years before interview
using a validated food frequency questionnaire
of 127 items (García-Closas R et al. 2007).
Micronutrients and macronutrients included
in the present analysis have been suggested
as important cofactors and methyl donors in
one-carbon metabolism (Stover 2009). We
calculated nutrient density variables by dividing the total estimated mass of daily food
consumed by the total estimated daily energy
intake (micrograms per day per kilocalorie).
Trace elements. We collected toenail clippings to estimate chronic exposure to trace
elements. Sample collection and experimental
methods used to measure trace elements level
have been reported previously (Amaral et al.
2012). Briefly, after cleaning and washing the
toenails to remove external contaminants,
we quantified elements at the Trace Element
Analysis Core (Dartmouth College, Hanover,
NH, USA), using inductively coupled plasma–
mass spectrometry (Hopkins et al. 2004). We
digested the samples with Optima® Nitric
Acid (Fisher Scientific, St. Louis, MO, USA)
at 105°C followed by addition of hydrogen
peroxide and further heating the dilution with
deionized water. We recorded gravimetrically
all sample preparation steps. As a quality control, each batch of analyses included six standard reference material samples with known
trace element content (GBW 07601, powdered human hair; China National Analysis
Center for Iron and Steel, Beijing, China)
and six analytic blanks, along with the study
samples. In total, we determined concentrations (micrograms per gram) of 12 trace
elements (aluminum, arsenic, cadmium, chromium, copper, iron, lead, manganese, nickel,
selenium, v anadium, and zinc).
Genotyping. For genotype assays, we
extracted DNA from leukocytes as described
previously (García-Closas M et al. 2005).
We determined genotypes at the Core
Genotyping Facility of the Division of
Cancer Epidemiology and Genetics, National
Cancer Institute, MD, USA. We selected for
the analysis a total of 515 SNPs in 24 genes
involved in the one-carbon metabolism pathway, including DNA methylation and arsenic
metabolism [for a list of the 24 genes evaluated, see Supplemental Material, Table S1
(http://dx.doi.org/10.1289/ehp.1206068)].
We selected these genes because they are critical for the one-carbon metabolism pathway
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(Lee YL et al. 2009; Ulrey et al. 2005).
Previously, we described in detail methods
of the genotyping process (García-Closas M
et al. 2005, 2007; Rothman et al. 2010). We
genotyped SNPs using Illumina Infinium®
Human1M-Duo, Illumina GoldenGate®
(Illumina, San Diego, CA, USA) and
TaqMan® (Applied Biosystems, Foster City,
CA, USA) assays (for a complete list of SNPs
according to assay, see Supplemental Material,
Table S2). In addition, we estimated associations between LINE-1 methylation and
glutathione S-transferase mu 1 (GSTM1), glutathione S-transferase theta 1 (GSTT1), and
N-acetyltransferase 2 (NAT2) variants because
of their relevance to bladder cancer (Cash
et al. 2012). These variants were determined
as described by García-Closas M et al. (2005).
All genotypes included in the study were in
Hardy-Weinberg equilibrium in the study
population (p > 0.05) (data not shown).
Statistical analysis. The distribution of
LINE-1 methylation levels was slightly bimodal
and positively skewed [see Supplemental
Material, Figure S1 (http://dx.doi.org/10.1289/
ehp.1206068)]. To estimate associations
between LINE-1 methylation levels and each
of the variables considered, we fitted bivariate
robust linear regression models and calculated
the corresponding beta coefficients and 95%
confidence intervals (CIs). Characteristics analyzed as continuous variables were age, micronutrient intakes, fruit and vegetable intakes,
and toenail concentrations of trace elements.
Characteristics analyzed as categorical variables
were BMI (< 25.0, 25.0–26.99, 27.0–29.99,
≥ 30.0), smoking status (non-, occasional, former, current smoker), and tobacco type (nonsmoker, blond only, black only, blond and
black, unknown).
To identify SNPs for detailed assessment, we first used the Fisher’s exact test
to screen SNPs that were significantly associated (p < 0.05) with LINE-1 methylation
categorized according to tertiles (< 56.7%,
56.7–58.6%, and > 58.6%) according
to codominant mode of inheritance. The
22 SNPs identified for further analyses [listed
in Supplemental Material, Table S3 (http://
dx.doi.org/10.1289/ehp.1206068)] were subsequently modeled according to all modes of
inheritance (additive, codominant, dominant,
and recessive). The mode of inheritance that
best predicted LINE-1 methylation is reported.
In addition to age and sex, adjusted robust
linear regression models for each potential predictor included region, which may be related
to diet, micronutrients (Gabriel et al. 2006),
and environmental pollution and smoking
status, which may be related to trace elements
(Moerman and Potts 2011). We also did a
sensitivity analysis without adjusting for smoking status to see whether there was a change
in the beta estimates. We included all the
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515 SNPs in the analysis regardless of linkage disequilibrium. The association between
LINE-1 methylation and potential predictors was assessed in the multivariable adjusted
model stratifying by sex. Because arsenic and
rs7085104 in arsenic (+3 oxidation state)
methyltransferase (AS3MT), which is involved
in arsenic metabolism, were individually associated with LINE-1 methylation, we assessed
the presence of effect modification by including a multiplicative interaction term in a
model adjusted for age, sex, region, and smoking status. The Wald test was used to calculate
the interaction p-value. We corrected for multiple testing using the Bonferroni method. We
conducted a sensitivity analysis, excluding 42
individual participants who had a CV > 4%

for LINE-1 methylation in duplicate samples.
This exclusion did not result in substantial
differences in the beta coefficients; therefore,
those participants remained in the analyses
(data not shown). All statistical tests were twosided, and p ≤ 0.05 was considered significant.
We carried out all data analyses using Stata/
SE version 10.1 (StataCorp, College Station,
TX, USA).

Results
The characteristics of the 892 participants in the present study and median and
mean LINE-1 methylation levels according
to each variable of interest are provided in
Supplemental Material, Table S4 (http://
dx.doi.org/10.1289/ehp.1206068). The

majority of the study participants were
male (89%) and regular (former or current) smokers (63.9%), with a median age
of 66 years [interquartile range (IQR) = 13].
The mean LINE-1 methylation level was
58.9% (SD = 5.3%) with minimum and
maximum value of 37.9% and 85.7%, respectively. Table 1 shows the association between
LINE-1 methylation levels and characteristics
of study subjects. In the bivariable robust linear regression analysis, only toenail arsenic and
nickel concentrations were significantly associated with LINE-1 methylation. However, in
multivariable robust linear regression models adjusted for age, sex, region, and smoking status, the levels of LINE-1 methylation
were significantly lower in women than in

Table 1. Association between LINE-1 methylation level and individual characteristics of study subjects in the SBC/EPICURO study.
Variables
Age (years)
Sex
Men
Women
Region
Barcelona
Vallès
Elche
Tenerife
Asturias
BMI (kg/m²)
< 25.0
25.0–26.99
27.0–29.99
≥ 30.0
Missing data
Smoking status
Nonsmoker
Occasional smoker
Former smoker
Current smoker
Missing data
Tobacco type
Nonsmoker
Blond only
Black only
Blond and black
Unknown
Missing data
Controls’ diagnosis
Hernia
Fracture and trauma
Hydrocele
Other abdominal surgery
Other diseases
Dietary intakec
Vitamin B1 (µg/day/kcal)
Vitamin B2 (µg/day/kcal)
Vitamin B3 (µg/day/kcal)
Vitamin B6 (µg/day/kcal)
Vitamin B12 (µg/day/kcal)
Folate (µg/day/kcal)
Protein (µg/day/kcal)
Alcohol (µg/day/kcal)
Fruit (g/day/kcal)
Vegetable (g/day/kcal)
Fruit and vegetable (g/day/kcal)

Unadjusted

Adjusted

n
892

LINE-1 methylation
mean (95% CI)
—

β (95% CI)
–0.004 (–0.02, 0.01)

p-Value
0.6

n
889

β (95% CI)a,b
–0.006 (–0.02, 0.01)

792
100

59.0 (58.6, 59.4)
58.0 (57.1, 58.8)

Ref
–0.4 (–0.9, 0.05)

0.08

789
100

Ref
–0.7 (–1.2, –0.1)

0.02

168
135
73
145
371

59.3 (58.5, 60.2)
58.3 (57.5, 59.0)
58.2 (57.1, 59.3)
58.6 (57.8, 59.4)
59.2 (58.6, 59.8)

Ref
–0.2 (–0.7, 0.4)
–0.4 (–1.1, 0.2)
–0.1 (–0.7, 0.4)
0.2 (–0.3, 0.6)

0.5
0.2
0.7
0.5

168
135
73
144
369

Ref
–0.2 (–0.7, 0.3)
–0.5 (–1.1, 0.2)
–0.1 (–0.6, 0.4)
0.1 (–0.3, 0.6)

0.5
0.1
0.7
0.6

372
148
120
57
195

58.8 (58.3, 59.3)
58.9 (57.9, 59.9)
59.0 (58.1, 59.8)
58.8 (57.5, 60.2)

Ref
–0.2 (–0.6, 0.3)
0.1 (–0.3, 0.6)
–0.08 (–0.7, 0.6)

0.5
0.6
0.8

370
148
120
57

Ref
–0.2 (–0.6, 0.3)
0.2 (–0.3, 0.7)
–0.03 (–0.7, 0.6)

0.4
0.4
0.9

255
66
329
239
3

58.2 (57.7, 58.7)
60.0 (58.4, 61.5)
58.9 (58.3, 59.5)
59.4 (58.6, 60.2)

Ref
0.4 (–0.2, 1.1)
–0.2 (–0.5, 0.3)
–0.2 (–0.6, 0.2)

0.2
0.6
0.4

255
66
329
239

Ref
0.3 (–0.3, 1.0)
–0.3 (–0.7, 0.1)
–0.4 (–0.9, 0.07)

0.3
0.2
0.1

255
99
219
154
97
68

58.2 (57.7, 58.7)
58.5 (57.6, 59.5)
59.6 (58.8, 60.4)
58.7 (57.8, 59.6)
59.3 (58.2, 60.5)

Ref
–0.5 (–1.0, 0.09)
0.06 (–0.4, 0.5)
–0.3 (–0.8, 0.2)
–0.01 (–0.6, 0.6)

0.1
0.8
0.2
0.9

255
99
218
154
97

Ref
–0.7 (–1.3, –0.08)
–0.2 (–0.6, 0.3)
–0.6 (–1.1, –0.07)
–0.12 (–0.7, 0.5)

0.03
0.5
0.03
0.7

332
263
122
99
76

58.8 (58.2, 59.4)
59.3 (58.6, 60.0)
58.7 (57.8, 59.6)
58.3 (57.4, 59.2)
59.2 (57.9, 60.5)

Ref
–0.2 (–0.5, 0.2)
0.2 (–0.3, 0.7)
–0.2 (–0.7, 0.3)
0.01 (–0.9, 0.6)

0.4
0.4
0.4
0.9

330
262
122
99
76

Ref
–0.02 (–0.4, 0.4)
0.2 (–0.3, 0.7)
–0.09 (–0.6, 0.5)
0.2 (–0.4, 0.8)

0.9
0.5
0.7
0.5

645
645
645
645
645
645
645
645
639
640
639

—
—
—
—
—
—
—
—
—
—
—

0.3
0.7
0.7
0.1
0.1
0.4
0.4
0.8
0.9
0.3
0.6

644
644
644
644
644
644
644
644
638
639
638

0.5 (–0.6, 1.6)
0.1 (–0.5, 0.8)
0.01 (–0.05, 0.08)
0.6 (–0.2, 1.4)
–0.04 (–0.09, 0.01)
0.001 (–0.002, 0.004)
0.01 (–0.01, 0.03)
–0.002 (–0.02, 0.02)
0.0001 (–0.001, 0.002)
0.001 (–0.001, 0.003)
0.0003 (–0.0008, 0.001)

0.6 (–0.6, 1.7)
0.2 (–0.5, 0.8)
0.02 (–0.05, 0.09)
0.8 (–0.05, 1.6)
–0.03 (–0.08, 0.02)
0.003 (–0.001, 0.01)
0.01 (–0.01, 0.03)
–0.01 (–0.03, 0.02)
0.0001 (–0.001, 0.002)
0.002 (–0.001, 0.004)
0.0005 (–0.0007, 0.002)

p-Value
0.5

0.3
0.6
0.5
0.07
0.3
0.1
0.4
0.5
0.9
0.1
0.4
Table continued
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men (adjusted β = –0.7; 95% CI: –1.2, –0.1,
p = 0.02) and in smokers of blond tobacco
only (adjusted β = –0.7; 95% CI: –1.3, –0.08,
p = 0.03) and of both blond and black tobacco
(adjusted β = –0.6; 95% CI: –1.1, –0.07,
p = 0.03) compared with nonsmokers. Toenail
arsenic concentration also was negatively associated with LINE-1 methylation (adjusted
β for a 1-µg/g increase = –3.6; 95% CI:
–5.9, –1.2, p = 0.003). In contrast, LINE-1
levels were positively associated with 1-µg/g
increases in toenail concentrations of iron
(adjusted β = 0.002; 95% CI: 0.001, 0.004,
p = 0.009) and nickel (adjusted β = 0.02;
95% CI: 0.005, 0.03, p = 0.004). BMI, B
vitamins, folate, total protein, alcohol, and
fruit and/or vegetable intake were not significantly associated with LINE-1 methyla
tion regardless of adjustment for covariates
(Table 1). Results from the multivariable analyses without adjusting for smoking status
done as a sensitivity analysis were not different
from the associations above (see Supplemental
Material, Table S5). If we were to correct for
multiple comparisons by Bonferroni method,
none of the above would be significant.
Out of the 515 genetic variants assessed,
22 passed a first screening using Fisher’s
exact test (p ≤ 0.05 according to codominant mode of inheritance) [see Supplemental
Material, Table S3 (http://dx.doi.org/10.1289/
ehp.1206068)]. Of these, 7 SNPs in five genes
were significantly associated with LINE-1
methylation based on multivariable models

adjusted for age, sex, region, and smoking status (Table 2; model-based estimates for the
15 SNPs that were not significantly associated with LINE-1 methylation are reported in
Supplemental Material, Table S6.) Significant
positive associations were estimated for DNA
(cytosine-5-)-methyltransferase 3 alpha
(DNMT3A)-rs7581217 (per allele: adjusted
β = 0.3; 95% CI: 0.1, 0.6, p = 0.002); transcobalamin II (TCN2)-rs9621049 (recessive: adjusted β = 4.2; 95% CI: 2.8, 5.7,
p = 4.7 × 10–9), TCN2-rs4820887 (recessive: adjusted β = 4.0; 95% CI: 2.5, 5.6,
p = 4.8 × 10–7) and TCN2-rs9606756 (recessive: adjusted β = 1.9; 95% CI: 0.5, 3.3,
p = 0.008); and AS3MT-rs7085104 (recessive:
adjusted β = 0.7; 95% CI: 0.3, 1.2, p = 0.001).
In addition, significant associations under the
codominant mode of inheritance (based on
global p-values) were estimated for solute carrier family 19 (folate transporter), member 1
(SLC19A1)-rs914238 (TC vs. TT, β = 0.5;
95% CI: 0.08, 0.8; CC vs. TT, β = –0.3;
95% CI: –0.7, 0.2; global p = 0.0007) and
5,10-methenyltetrahydrofolate synthetase
(MTHFS)-rs1380642 (CT vs. CC, β = 0.3;
95% CI: –0.08, 0.6; TT vs. CC, β = –0.8;
95% CI: –1.6, 0.09; global p = 0.05). After
correcting for multiple testing using the
Bonferroni method, TCN2-rs9621049
and TCN2-rs4820887 remained significant
(p < 0.05).
A significant interaction (p = 0.01)
was observed between arsenic and

AS3MT-rs7085104 on LINE-1 methylation
(adjusted β for a 1-μg/g increase in As = –4.1;
95% CI: –6.6, –1.7, p = 0.001 for genotype
AA/AG; and adjusted β for a 1-μg/g increase
in As = 10.2; 95% CI: –3.2, 23.7, p = 0.1 for
genotype GG).
After simultaneously adjusting for age,
geographic region, and all factors that were
significant predictors of LINE-1 methyla
tion (sex; tobacco type; toenail arsenic, iron,
and nickel; and the 5 SNPs noted above),
associations with sex, arsenic, nickel, iron,
DNMT3A-rs7581217, TCN2-rs9621049,
and MTHFS-rs1380642 remained significant. The association with blond tobacco was
nonsignificant although the direction of the
point estimate remained unchanged. The
association between rs9606756, rs4820887,
and LINE-1 methylation become nonsignifcant [see Supplemental Material, Table S7
(http://dx.doi.org/10.1289/ehp.1206068)].
This might be due to reduced sample size in
the simultaneously adjusted model due to
missing data.

Discussion
In the present study, we used a comprehensive approach to assess associations of
genetic and non-genetic factors with LINE-1
methylation in a group of participants
20–81 years of age. Lower levels of LINE-1
methylation were found among women
compared with men, and among smokers of
blond tobacco compared with nonsmokers.

Table 1. Continued.
Variables
Toenail trace elements (µg/g)d
Aluminum
Arsenic
Cadmium
Chromium
Copper
Iron
Lead
Manganese
Nickel
Selenium
Vanadium
Zinc
NAT2 phenotype
Rapid/intermediate acetylator
Slow acetylator
Missing data
GSTM1 genotype
(+/+, +/–)
(–/–)
Missing data
GSTT1 genotype
(+/+, +/–)
(–/–)
Missing data

Unadjusted

Adjusted

n

LINE-1 methylation
mean (95% CI)

β (95% CI)

p-Value

n

658
659
659
658
659
657
659
659
659
659
651
659

—
—
—
—
—
—
—
—
—
—
—
—

–0.003 (–0.008, 0.002)
–2.9 (–5.2, –0.6)
0.08 (–0.4, 0.5)
0.06 (–0.01, 0.1)
–0.002 (–0.06, 0.05)
–0.002 (–0.006, 0.002)
–0.05 (–0.1, 0.03)
–0.03 (–0.1, 0.09)
0.02 (0.006, 0.03)
0.1 (–0.8, 1.0)
–0.7 (–2.7, 1.3)
–0.002 (–0.004, 0.001)

0.2
0.02
0.7
0.09
0.95
0.4
0.2
0.7
0.002
0.8
0.5
0.2

658
659
659
659
659
658
659
659
659
659
651
659

–0.003 (–0.008, 0.002)
–3.6 (–5.9, –1.2)
0.1 (–0.3, 0.6)
–0.01 (–0.05, 0.03)
–0.01 (–0.07, 0.04)
0.002 (0.001, 0.004)
–0.06 (–0.1, 0.02)
–0.05 (–0.2, 0.06)
0.02 (0.005, 0.03)
0.2 (–0.7 1.2)
–0.9 (–2.8, 1.2)
–0.001 (–0.004, 0.002)

389
498
5

59.0 (58.4, 59.6)
58.8 (58.4, 59.2)

Ref
0.2 (–0.1, 0.5)

0.3

388
496

Ref
0.2 (–0.1, 0.5)

0.2

421
462
9

58.9 (58.3, 59.4)
59.0 (58.5, 59.4)

Ref
0.04 (–0.3, 0.4)

0.8

419
461

Ref
0.01 (–0.3, 0.3)

0.9

688
198
6

59.0 (58.6, 59.4)
58.5 (57.9, 59.2)

Ref
–0.2 (–0.6, 0.2)

0.3

685
198

Ref
–0.2 (–0.6, 0.2)

0.4

β (95% CI)a,b

p-Value
0.2
0.003
0.6
0.6
0.6
0.009
0.2
0.4
0.004
0.6
0.4
0.4

The exposure contrast for trace elements is 1 μg/g and for dietary variables is 1 μg/day/kcal.
aAdjusted for age, sex, region, and smoking status (non-, occasional, former, current smoker). Tobacco type’s β is not adjusted for smoking status. bThe number of observations are
reduced by three because of missing data on smoking status. cData available for those who completed food frequency questionnaire. dData available for those who provided toenail
for trace element assessment.
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In addition, toenail concentrations of arsenic
were also negatively associated with LINE-1
methylation. On the other hand, LINE-1
methylation levels were positively associated with toenail concentrations of iron and
nickel, and with seven variants in DNMT3A,
TCN2, AS3MT, SLC19A1, and MTHFS
genes.
Our findings support previous results
showing that women have significantly lower
levels of LINE-1 methylation (El-Maarri
et al. 2007, 2011; Wilhelm et al. 2010; Zhu
et al. 2012). DNA methylation is important
for X-chromosome inactivation in women
(Jones and Liang 2009), and although LINE-1
sequences do not seem to be the major mecha
nism involved in this process, they may be
involved in spreading the X-inactivation signal
across the chromosome (Bailey et al. 2000).
In support of this, a recent study showed that
LINE-1 sequences were hypomethylated in the
inactive X-chromosome (Singer et al. 2012). A
small study of 33 men and 33 women reported
lower levels of blood SAM in women (Poirier
et al. 2001). Hormonal factors may also contribute to the difference in methylation levels
between sexes. However, a recent in vitro study
assessing the roles of estrogen, progesterone,
and dihydrotestosterone on DNA methylation
in four cell lines found no detectable effect
of these hormones on methylation levels at
the LINE-1 and Alu repeats (El-Maarri et al.
2011). Further studies are needed to decipher
the relationship between sex and LINE-1
methylation.
Because tobacco smoking is an important contributor to disease and is a modifiable
behavioral factor, there has been much interest in the relationship between smoking and
DNA methylation. Our findings are in line
with other studies that reported no association between LINE-1 methylation and smoking status (Terry et al. 2011). In the present
study, we found that subjects who smoked

blond tobacco had lower levels of global DNA
methylation than nonsmokers. An experimental study has shown that cigarette smoke
condensates can induce DNA demethyla
tion in repeat elements such as LINE-1 and
D4Z4 (Liu et al. 2010). Both black and blond
tobacco cause disease although the former is
more mutagenic, reflective of the higher levels of N-nitrosamines and aromatic amines in
smoke produced by black tobacco (Malaveille
et al. 1989). Our findings suggest that the toxic
effects of blond tobacco could be mediated by
modulating the epigenetic landscape. This may
have a public health implication given epigenetic alterations are reversible.
We also provide evidence that arsenic
levels were inversely associated with LINE-1
methylation, and that arsenic may have a
strong effect on LINE-1 methylation. For
every 1-μg/g increase in arsenic there was a
3.6% decrease in DNA methylation level. This
inverse association is in agreement with that
from a population-based study that used a
similar assay to assess LINE-1 methylation
levels and toenail concentrations of arsenic
(Wilhelm et al. 2010), as well as with several other experimental studies (Reichard and
Puga 2010; Ren et al. 2011). The mechanisms
through which arsenic exposure influences
DNA methylation are not fully understood.
Studies in cell lines and mouse models
exposed to arsenic for ≤ 22 and 48 weeks,
respectively, have shown that prolonged exposure to sodium arsenite resulted in decreased
global DNA methylation, and inhibition
of DNA (cytosine-5-)-methyltransferase 1
(DNMT1), DNMT3A, and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B)
gene expression (Reichard and Puga 2010;
Ren et al. 2011). It is likely that through
the combined effect of depleting the cellular
pool of SAM and inhibiting the activity of
DNMTs, both inorganic and organic arsenic
may decrease global DNA methylation.

We are not aware of any human studies associating iron and nickel levels and
global DNA methylation. In the present
study, iron and nickel showed a small but
significant positive association with LINE-1
methylation level. Genes involved in hepatocellular carcinoma (HCC) have been
found to be hypermethylated in hereditary
hemochromatosis, a disease characterized by
chronic iron overload that is a risk factor for
HCC (Lehmann et al. 2007). Iron, together
with 2-oxoglutarate and oxygen, is an essential cofactor for the ten-eleven translocation
(TET) family of proteins that hydroxylate
5-methylcytosine to 5-hydroxymethylcytosine
and further oxidize to 5-carboxylcytosine and
5-formylcytosine, which have all been suggested to be precursors for both active and
passive DNA demethylation (Bhutani et al.
2011). Experimental studies conducted in
Chinese hamster cell lines (G12) treated with
nickel chloride for up to 3 weeks have shown
that nickel chloride treatment leads to both
promoter hypermethylation and elevated
total genomic DNA methylation (Lee YW
et al. 1995, 1998). How nickel induces DNA
methylation is not yet understood, but it
has been proposed that nickel first induces
chromatin condensation followed by de novo
methylation of heterochromatic DNA
(Lee YW et al. 1995).
The three SNPs with the strongest associations with LINE-1 methylation were all
in TCN2, including two exonic SNPs that
result in missense substitutions (rs9606756
and rs9621049) and one intronic SNP
(rs4820887). SNPs rs9621049 and rs4820887
have a linkage disequilibrium r2 value of 0.8,
implying that the observed effect in LINE-1
methylation may eventually be attributed
to either of them. TCN2 encodes for trans
cobalamin II which binds and transports
vitamin B12 into the cell (Regec et al. 1995),
suggesting that variations in TCN2 could

Table 2. Association between LINE-1 methylation levels and SNPs in genes involved in the one-carbon metabolism pathway.
Unadjusted

dbSNP [chromosome,
Gene
position in the gene, locationa]
DNMT3A rs7581217 [2, intron, 25378448]
AS3MT rs7085104 [10, flanking 5’UTR, 104618863]

MAF
0.39
0.38

MTHFSc

0.18

rs1380642 [15, flanking 3’UTR, 77883926]

SLC19A1c rs914238 [21, flanking 5’UTR, 45840089]

0.49

TCN2d

rs9621049 [22, exon, 29343419]

0.11

rs9606756 [22, exon, 29336860]

0.12

rs4820887 [22, intron, 29346914]

0.10

n
875
751
124
585
258
32
231
435
209
864
11
864
11
866
9

MOI
Additive
Recessive
Codominant
Codominant
Recessive
Recessive
Recessive

Genotype
per allele T
AA/AG
GG
CC
CT
TT
TT
TC
CC
CC/CT
TT
AA/AG
GG
GG/GA
AA

β (95% CI)
0.3 (0.1, 0.6)
Ref
0.8 (0.3, 1.2)
Ref
0.3 (–0.05, 0.6)
–0.8 (–1.6, 0.07)
Ref
0.5 (0.09, 0.8)
–0.2 (–0.7, 0.2)
Ref
4.5 (3.1, 5.9)
Ref
2.2 (0.8, 3.6)
Ref
4.6 (3.0, 6.2)

p-Value
0.003
0.0008
0.03
0.0008

4.3 × 10–10
0.003
9.3 × 10–9

Adjusted
βb (95% CI)
0.3 (0.1, 0.6)
Ref
0.7 (0.3, 1.2)
Ref
0.3 (–0.08, 0.6)
–0.8 (–1.6, 0.09)
Ref
0.5 (0.08, 0.8)
–0.3 (–0.7, 0.2)
Ref
4.2 (2.8, 5.7)
Ref
1.9 (0.5, 3.3)
Ref
4.0 (2.5, 5.6)

p-Value
0.002
0.001
0.05
0.0007

4.7 × 10–9
0.008
4.8 × 10–7

Abbreviations: MAF, minor allele frequency; MOI, mode of inheritance.
aHuman Genome Build 36.3 location. bAdjusted for age, sex, region, and smoking status. cGlobal p-value for rs1380642 and rs914238 was estimated by using a two-degree-of-freedom
likelihood-ratio test. dLinkage disequilibrium (rs4820887 vs. rs9621049) r2 = 0.8.
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potentially impair the one-carbon metabolism
pathway by altering the cytoplasmic concentration of vitamin B12. TCN2-rs9606756
leads to an I23V substitution located at a
NAGNAG tandem acceptor site that is a target of alternative splicing (Hiller et al. 2006).
TCN2-rs9621049 leads to a S348F and may
also play a role in the availability of vitamin
B12 in the cell thereby affecting LINE-1
methylation levels.
Four SNPs in other genes (DNMT3A-
rs7581217, AS3MT-rs7085104, MTHFS-
rs1380642, SLC19A1-rs914238) involved in
the one-carbon metabolism were also associated with global DNA methylation in our
study population. DNMT3A, a de novo DNA
methyltransferase, establishes the patterns of
methylation in early embryonic development,
along with DNMT3B, and cooperates with
DNMT1 to maintain the methylation of
repetitive sequences such as LINE-1 and Alu
elements (Jones and Liang 2009). Recurrent
mutations in DNMT3A have been associated
with adult hematologic malignancies (Ley
et al. 2010; Yan et al. 2011), and mice lacking
Dnmt3a die within the first weeks of postnatal life (Robertson 2005). The product of
AS3MT catalyzes the conversion of trivalent
arsenic by adding a methyl group to mono
methylarsonic acid and dimethylarsonic acid
(Ren et al. 2011); monomethylarsonic acid
being the most toxic metabolite (Engström
et al. 2011). rs7085104, located in the promoter region of AS3MT, has been associated
with arsenic metabolism, as evidenced by differences in urinary concentration of arsenic
metabolites (Engström et al. 2011; Valenzuela
et al. 2009). We also observed a significant
interaction of this SNP with levels of arsenic
on LINE-1 methylation levels. Whereas subjects with at least one copy of the major allele

had a 4.1% decrease in methylation level per
1-μg/g increase in arsenic, which is comparable to the overall population (–3.6%), those
homozygous for the variant allele had a 10%
increase in LINE-1 methylation. These findings support the putative functionality of the
association. The product of MTHFS catalyzes
the conversion of 5-formyltetrahydrofolate
to 5,10-methenyltetrahydrofolate and a
genome-wide association study reported an
association between a variant in this gene and
chronic kidney disease (Kottgen et al. 2008).
SLC19A1 is a ubiquitously expressed major
transporter of folate and antifolates and regulator of the intracellular concentrations of
folate (Matherly et al. 2007). Common variants in this gene have been associated with
plasma folate levels, various types of cancer
(esophageal, gastric, and acute lymphoblastic
leukemia), and altered methotrexate transport
and adverse effects of methotrexate (Matherly
et al. 2007).
Among the limitations of the study is that
the majority of paraticipants were of advanced
age (mean = 64 years of age, SD = 10 years)
and male. This may explain the lack of
association between DNA methylation and
age in our study population, in contrast with
other studies that included subjects with a
broader age range (Fraga et al. 2005). Thus,
our findings refer to an adult population of
mostly men. Results were consistent with estimates for the population as a whole when
stratified by sex, with the exception of nickel,
tobacco type, and MTHFS-rs1380642, which
become nonsignificant when the point estimates were in the same direction (data not
shown). These differences may reflect reduced
power to estimate associations among women
as a result of the small sample size. The presence of missing data for some of the variables

Appendix 1
Spanish Bladder Cancer/EPICURO Study investigators
Institut Municipal d’Investigació Mèdica, Universitat Pompeu Fabra, Barcelona–Coordinating Center
(M. Kogevinas, N. Malats, F.X. Real, M. Sala, G. Castaño, M. Torà, D. Puente, C. Villanueva,
C. Murta-Nascimento, J. Fortuny, E. López, S. Hernández, R. Jaramillo, G. Vellalta, L. Palencia,
F. Fermández, A. Amorós, A. Alfaro, G. Carretero); Hospital del Mar, Universitat Autònoma de
Barcelona, Barcelona (J. Lloreta, S. Serrano, L. Ferrer, A. Gelabert, J. Carles, O. Bielsa, K. Villadiego);
Hospital Germans Trias i Pujol, Badalona, Barcelona (L. Cecchini, J.M. Saladié, L. Ibarz); Hospital
de Sant Boi, Sant Boi de Llobregat, Barcelona (M. Céspedes); Consorci Hospitalari Parc Taulí,
Sabadell (C. Serra, D. García, J. Pujadas, R. Hernando, A. Cabezuelo, C. Abad, A. Prera, J. Prat);
Centre Hospitalari i Cardiològic, Manresa, Barcelona (M. Domènech, J. Badal, J. Malet); Hospital
Universitario de Canarias, La Laguna, Tenerife (R. García-Closas, J. Rodríguez de Vera, A.I. Martín);
Hospital Universitario Nuestra Señora de la Candelaria, Tenerife (J. Taño, F. Cáceres); Hospital General
Universitario de Elche, Universidad Miguel Hernández, Elche, Alicante (A. Carrato, F. García-López,
M. Ull, A. Teruel, E. Andrada, A. Bustos, A. Castillejo, J.L. Soto); Universidad de Oviedo, Oviedo,
Asturias (A. Tardón); Hospital San Agustín, Avilés, Asturias (J.L. Guate, J.M. Lanzas, J. Velasco);
Hospital Central Covadonga, Oviedo, Asturias (J.M. Fernández, J.J. Rodríguez, A. Herrero); Hospital
Central General, Oviedo, Asturias (R. Abascal, C. Manzano, T. Miralles); Hospital de Cabueñes, Gijón,
Asturias (M. Rivas, M. Arguelles); Hospital de Jove, Gijón, Asturias (M. Díaz, J. Sánchez, O. González);
Hospital de Cruz Roja, Gijón, Asturias (A. Mateos, V. Frade); Hospital Alvarez-Buylla, Mieres, Asturias
(P. Muntañola, C. Pravia); Hospital Jarrio, Coaña, Asturias (A.M. Huescar, F. Huergo); Hospital
Carmen y Severo Ochoa, Cangas, Asturias (J. Mosquera).
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might have resulted in decreased power, but
even with the available sample size we were
able to reproduce previous results and identify novel predictors of LINE-1 methylation.
Furthermore, although the study subjects
were recruited from hospitals, none of reasons
for hospitalization were significantly associated with LINE-1 methylation.
Strengths of the study include its size
and the availability and quality of individual
data on demographics, lifestyle, environmental exposures, and genetics. Additionally, we
assessed LINE-1 methylation levels, which
are considered a good marker of global DNA
methylation (Yang et al. 2004), using pyro
sequencing, which gives accurate and reproducible measurements (Estécio et al. 2007; Laird
2010; Tost and Gut 2007). Furthermore, this
assessment was made using DNA from granulocytes, thereby avoiding a possible effect of cell
blood count in our study.
To the best of our knowledge, this is the
first study to identify seven SNPs in association with changes in LINE-1 methylation and
to integrate different types of information to
assess the determinants of global methylation
in blood DNA. Integration of both internal
and external exposure data in this study is a
step forward in understanding how the exposome modulates DNA methylation patterns.

Conclusions
The present study provides further evidence
that DNA methylation levels are influenced by variants in genes involved in the
one-carbon metabolism pathway, and exposure to trace elements and tobacco smoke.
Given the fact that smoking and some of the
genetic variants and trace elements associated with LINE-1 methylation in the present
study have also been associated with adverse
health outcomes including cancer, our results
provide additional insight into the potential
mechanism through which these agents participate in the development of those diseases.
Furthermore, these factors should be considered as potential confounders in etiologic
and interventional studies analyzing the role
of DNA methylation in disease. Nevertheless,
future studies are required to replicate and
extend our findings in different populations.
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